Abg Realty

Raytheon BBN working on Star Trek tech

If you thought inventing the Internet was a big enough accomplishment that you can rest on your laurels, you can’t work for Raytheon BBN Technologies — the actual inventors of said Internet. DARPA agrees, and is now funding Raytheon BBN in a program to create super high-capacity broadband encrypted communications that is all but unbreakable, […]

Read more

Construction is underway for 600,000 s/f Northborough Crossing retail project

Rendering, Northborough Crossing – Northborough, MA Shown (from left) are Douglass Karp, lt. governor Tim Murray and Stephen Karp. Northborough, MA Construction is well underway for Northborough Crossing, a 600,000 s/f open-air retail center being developed by New England Development in partnership with Brendon Properties and The Wilder Companies. The first new, major retail project […]

Read more

Sanofi-Aventis does deal with Avila

Avila Therapeutics, Inc., a privately held biotechnology company, will receive an upfront payment of up to $40 million from French drug maker Sanofi-aventis, as part of a research collaboration aimed at developing cancer drugs. Cambridge, Mass-based biotech will receive up to $154 million in milestone payments for any drug that is eventually approved. Waltham, Mass.-based […]

Read more

Tenant allowances a chore to understand

We keep hearing that landlords are bending over backwards — beyond offering low lease rates — to retain and recruit tenants. Details over recently awarded allowances for tenant improvements indicate that some property owners are more flexible than others. A case in point is this week’s disclosure that Boston Properties Inc. gave the Federal Home […]

Read more

Promethean looking for new digs

Cambridge’s first cleantech-focused incubator is about to be replaced – by a biotech building. Solar technology developer Promethean Power Systems had been providing shop space for energy startups in a building near Lechmere Square. Now, after less than a year, it is out looking for new digs, after the owner of the building sold it […]

Read more

Semprus BioSciences raises Series B funds

Cambridge-based biomedical company focused on antibacterial coatings Semprus BioSciences Inc. has closed on an $18 million Series B financing roubnd, led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners. According to Semprus officials, 5AM Ventures and Pangaea Ventures, both of whom invested in the company’s Series A financing, participated […]

Read more

Compare